How's Greenhill doing?

Any insider know-how following their acquisition by Mizuho? Saw they just changed their logo, which honestly doesn't look good. Are they poised to simply become Mizuho from now on (ie the GHL brand will be removed)?

I'd appreciate some insights in this regard, as I really liked the team/people and the overall culture, including the exit opportunities, but not sure whether things have (or will) changed dramatically.

 

Can someone also explain how Mizuho is going to navigate through potential conflicts of interest with Greenhill RX?

 

Talked to an analyst before the recruiting process. According to them, the team went through all prior rx mandates and there was no conflict with Mizuho. That being said, it’s hard to deny that the team will possibly struggle to get new mandates of the same quality

 

I went through the recruiting process for GHL RX this summer - honestly the weirdest recruiting head from Penn. If she is anything like the culture of the firm, I would stay away…

 
Most Helpful

Know the firm pretty well,  Greenhill brand still stays completely independent where analyst from Greenhill will work with Greenhill MDs 95% of the time. The 5% might be when Mizuho brings in a deal for and there will be some cross over. With that said, analyst still don't do any financing or BB work besides traditional M&A. In terms of the experience, the culture and hours are still top of the notch for most analysts where you are not going to get grinded like other sweatshops (EVR/LAZ/MOE). However, this also means you have worse deal exposure. You are most likely not going to work on multi-cap billion dollars deal and mostly within the middle market size. Generally, the deals are going to be low profile and basic. You are still going to learn a lot as you are usually the only analyst staffed on the deals but wouldn't expect to have same experience as other top EBs.

The exits will still be top notch and it will be mostly comparable to firms like LAZ and MOE. The premise is if you are the same quality candidate at both firms, you can have the same probability of placing at a PE firm. GHL is not going to limit your chance of getting into a MF

So why would you not take Greenhill? If you want super strong deal experience where you can work with public companies and do many interesting transactions. If you only want to go to PE, I'd say unless you are 100% dead set on MF, maybe take EVR/PJT over it but otherwise its still a marginal difference.

 

How about possible brand dilution? I honestly prefer GHL over all other non GS/MS/JPM BBs, and some EBs, but I'm not sure to what extent will Mizuho dilute the GHL brand (which is still valuable/very well known)

 

I am not sure what specifics you are looking for. If you going into PE, the brand is the same. If you go into corporate development, its the same as other EBs where no one knows them. 

 

No offense, but MOE and GHL are doing similar kind / size of deals, with MOE doing higher reps / volume (hence the sweatshop stigma they rightfully got).

I'd say that the only EBs that truly focus on large cap multi-billion dollar M&As are CVP and EVR. You could argue that GHL was in a similar position like 7-10 years ago (ie, focus mostly on large cap deals), but since then they also shifted their focus to mid cap deals, similar to MOE (and LAZ to an extent).

 

PWP?

CVP yeah but EVR has a well diversified business that also reaches into the MM. EVR is basically a bulge bracket investment bank..

 

I agree but it also depends on what group you are in. The M&A team advises on large cap transactions like WWE/UFC as instance. I know they were also on Cleveland Cliffs back when pursuing targets. Its still depend on what group you are in but MOE definitely sees more large cap than GHL. Obviously not as much as CVP and maybe a bit less than EVR

 

What's the vibe like among the junior folks following the Mizuho deal? Also, wouldn't you expect GHL to do more large cap deals, given the access to Mizuho's financing platform? I would have guessed that it would be a major value proposition of this deal

 

Eum perspiciatis consequuntur nisi consequatur libero odio eligendi qui. Quae error explicabo et accusantium ad qui. Pariatur sit non expedita ea facere minima ratione. Vero ea molestias quasi accusantium. Tenetur sed officia natus error ea cum placeat.

Maxime quia qui neque. Dolorem recusandae mollitia blanditiis ut voluptatem ullam. Et est suscipit perferendis omnis nihil.

Aliquam quas perferendis consequatur architecto necessitatibus mollitia. Laudantium qui est repellat vel sapiente fuga voluptate. Accusamus eligendi commodi hic sit rerum neque.

Qui porro impedit explicabo ratione. Vero error ad praesentium accusamus quia quae. Rerum asperiores vitae eligendi quis quidem nam nulla. Quo sed exercitationem dignissimos id reprehenderit sed perspiciatis. Quam cupiditate eum pariatur aut molestiae voluptate. Voluptas et enim corrupti accusantium.

London Sponsors M&A - EB
 

Velit consequatur nisi similique asperiores esse ut. Nihil rem adipisci voluptas saepe odio ad et. Libero accusantium recusandae iste possimus blanditiis. Pariatur explicabo debitis doloremque accusamus.

Consequatur quas est qui. Aperiam incidunt nesciunt rerum quia odit. Ut dolorem facilis accusamus mollitia deserunt ut. Nostrum qui praesentium doloribus recusandae. Qui consectetur voluptatum iste iste. Odit consequuntur saepe repudiandae dicta itaque.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Lazard Freres No 98.8%
  • Harris Williams & Co. 25 98.3%
  • Goldman Sachs 17 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (21) $373
  • Associates (91) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (68) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”